Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 83

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 83
---
 April 4, 2017 No. 203
for Kyrgyz Republic. NewGenIvf in the future may become involved in governmental investigations, audits, reviews and assessments.
Any determination by a court or agency that NewGenIvf’s solutions or services violate, or cause its clients to violate,
applicable laws, regulations or other requirements could subject it or its clients to civil, criminal, or administrative penalties.
Such a determination also could require it to change or terminate portions of its business, disqualify it from serving clients that
do business with government entities, or cause it to refund some or all of its service fees or otherwise compensate its clients. In
addition, failure to satisfy laws, regulations or other requirements could adversely affect demand for its solutions and could force
it to expend significant capital, research and development and other resources to address the failure. Even an unsuccessful
challenge by regulatory and other authorities or parties could be expensive and time-consuming, could result in loss of business,
exposure to adverse publicity, and injury to its reputation and could adversely affect its ability to retain and attract clients. If
NewGenIvf fails to comply with applicable laws, regulations and other requirements, its business, financial condition and results of
operations could be adversely affected. Such non-compliance could also require significant investment to address and may prove
costly. There are several additional state statutes, regulations, guidance and contractual provisions related to or impacting the
healthcare industry that may apply to its business activities directly or indirectly, including, but not limited to:

| ● | Licensing and Licensed Personnel. Many countries have licensure or registration requirements for entities acting as a medical services provider. The scope of these laws differs from country to country, and the application of such laws to the activities of fertility treatment is often unclear. Given the nature and scope of the solutions and services that NewGenIvf provides, it is required to maintain the License to Operate Medical Facility Business (Sor.Por.7), the License to Manage Medical Facility Business (Sor.Por.19), License to Certify the Standard of Service relating to Medically Assisted Reproductive Technology (KorThorPhor.9), and personnel licenses, i.e., license of medical professionals, nursing professionals, medical technology professionals, pharmaceutical professions and other applicable licenses in Thailand, Approval on Opening of Medical Clinic, Approval on Opening of Pharmacy and relevant approvals to conduct IVF, embryo implant and/or transfer activities issued by the Ministry of Health of Cambodia (“Camb